Intravenous P2Y12 Inhibition During PCI: Why, How, and Case Examples
Current Consensus on Pre-Treatment in the Setting of NSTE-ACS and the Role of IV Therapy
Mitul Patel, MD
The Nuts and Bolts of P2Y12 Descalation as Well as Switching from IV to Oral P2Y12 Inhibition
Ajay Kirtane, MD, SM
Case Studies in Complex PCI and Antiplatelet Decision-Making
Mitul Patel, MD
Discussion/Q&A
Ajay Kirtane, MD, SM, Mitul Patel, MD